- Consumable,
- Instruments,
- Services
Precision Oncology Market size was valued at USD 49.5 billion in 2022. It is expected to reach a value of USD 96.5 billion by 2029, growing at a CAGR of 10.1% from 2023 to 2029. Precision oncology is a cutting-edge kind of cancer therapy that makes sure your care is tailored to your particular type of cancer. It is the science of harnessing the unique genetics of each patient the genes that are mutated and cause their disease to spread to develop a personalized treatment plan based on those genetic mutations.
The global market provides a detailed overview of the market, which has been segmented by type and end-user. By type, the precision oncology market has been segmented into consumable Instruments and Services. The Consumable segment is likely to be the largest and fastest-growing in terms of type. Precision oncology is segmented into Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, and CROs based on the end-user. According to precision business insights, the Diagnostic Companies segment is predicted to register the fastest growth rate during the forecast period.
Precision Oncology Market Key Development:
- In July 2019, Pfizer collaborated with Syapse to advance cancer research. This collaboration was aimed to focus on molecular testing and therapy choices in precision oncology, thereby expanding the product portfolio.
Precision Oncology Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.1%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Precision Oncology Market Dynamics
Precision medicine combines molecular biology and system biology and is a new cancer treatment and prevention approach. Oncology precision medicine has emerged as potentially transformational, promising more excellent treatment outcomes for all cancer patients.
North-America Got Significant Share
Precision Oncology Market Regional Analysis
The North American market is expected to witness the highest market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The precision oncology market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The precision oncology market report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The precision oncology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The precision oncology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The precision oncology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Precision Oncology Market Segmentation
By Type
By end user
- Pharmaceuticals Companies,
- Biotechnology Companies,
- Diagnostic Companies,
- CROs
By Geography
- North America,
- Europe,
- Asia Pacific,
- Latin America and
- Middle East and Africa
Frequently Asked Questions
The precision oncology market is projected to expand at a CAGR of 10.1% during the forecast period.
The major global precision oncology market players are ??? Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc., NeoGenomics, QIAGEN, and Tepnel Pharma Services.
North America is the fastest-growing region for precision oncology market
| 1. Executive Summary |
| 2. Global Precision Oncology Market Introduction |
| 2.1. Global Precision Oncology Market Taxonomy |
| 2.2. Global Precision Oncology Market Definitions |
| 2.2.1. By End-user |
| 2.2.2. By Type |
| 3. Global Precision Oncology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Precision Oncology Market Dynamic Factors - Impact Analysis |
| 3.6. Global Precision Oncology Market Competition Landscape |
| 4. Global Precision Oncology Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Precision Oncology Market, By End-user, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Pharmaceuticals Companies |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Biotechnology Companies |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Diagnostic Companies |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. CROs |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Precision Oncology Market Forecast, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Consumable |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Instruments |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Services |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Precision Oncology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Region, 2023 - 2029 |
| 8. North America Precision OncologyMarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Pharmaceuticals Companies |
| 8.1.2. Biotechnology Companies |
| 8.1.3. Diagnostic Companies |
| 8.1.4. CROs |
| 8.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Consumable |
| 8.2.2. Instruments |
| 8.2.3. Services |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country, 2023 - 2029 |
| 8.5. North America Precision Oncology Market Dynamics Trends |
| 9. Europe Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Pharmaceuticals Companies |
| 9.1.2. Biotechnology Companies |
| 9.1.3. Diagnostic Companies |
| 9.1.4. CROs |
| 9.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Consumable |
| 9.2.2. Instruments |
| 9.2.3. Services |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029 |
| 9.5. Europe Precision Oncology Market Dynamics Trends |
| 10. Asia-Pacific Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Pharmaceuticals Companies |
| 10.1.2. Biotechnology Companies |
| 10.1.3. Diagnostic Companies |
| 10.1.4. CROs |
| 10.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Consumable |
| 10.2.2. Instruments |
| 10.2.3. Services |
| 10.3. Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029 |
| 10.5. Asia-Pacific Precision Oncology Market Dynamics Trends |
| 11. Latin America Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Pharmaceuticals Companies |
| 11.1.2. Biotechnology Companies |
| 11.1.3. Diagnostic Companies |
| 11.1.4. CROs |
| 11.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Consumable |
| 11.2.2. Instruments |
| 11.2.3. Services |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029 |
| 11.5. Latin America Precision Oncology Market Dynamics Trends |
| 12. Middle East and Africa Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Pharmaceuticals Companies |
| 12.1.2. Biotechnology Companies |
| 12.1.3. Diagnostic Companies |
| 12.1.4. CROs |
| 12.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Consumable |
| 12.2.2. Instruments |
| 12.2.3. Services |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029 |
| 12.5. MEA Precision Oncology Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Eagle Genomics |
| 13.2.2. ASEBIO |
| 13.2.3. Menarini Silicon Biosystems |
| 13.2.4. NanoString Technologies, Inc. |
| 13.2.5. NeoGenomics |
| 13.2.6. QIAGEN |
| 13.2.7. Tepnel Pharma Services |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- Eagle Genomics
- ASEBIO
- Menarini Silicon Biosystems
- NanoString Technologies, Inc.
- NeoGenomics
- QIAGEN
- Tepnel Pharma Services